Microchips and controlled-release drug reservoirs

Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology

Volumn 2, Issue 4, 2010, Pages 400-417

  Staples, Mark ^a  

^a Cusp PharmaTech Consulting LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVE INGREDIENTS; CONTROLLED DELIVERY; CONTROLLED RELEASE; DATA MANAGEMENT; DELIVERY DEVICE; DIAGNOSTIC FEEDBACK; DRUG DELIVERY SYSTEM; DRUG DEVELOPMENT; DRUG RESERVOIR; IMPLANTABLE DEVICES; IMPLANTABLE DRUG DELIVERY; LOCALIZED DELIVERY; MEDICAL CARE; MEDICAL DEVICES; MEDICAL NEEDS; NANO ELECTROMECHANICAL SYSTEMS; ON-DEMAND; POLYMER CHEMISTRY; SUB-OPTIMAL PERFORMANCE; THERAPEUTIC AGENTS; TREATMENT SITES;

BIOMEDICAL ENGINEERING; DRUG DELIVERY; MICROPROCESSOR CHIPS; PHYSIOLOGICAL MODELS;

FUNCTIONAL POLYMERS;

BIOLOGICAL MARKER; DIMETICONE; DRUG CARRIER; GLUCOSE; IMIGLUCERASE; POLY(METHYL METHACRYLATE); SILICON;

AUTOMATION; BIOMEDICAL MICROELECTROMECHANICAL SYSTEM; COMPUTER PROGRAM; DRUG ADMINISTRATION; DRUG DELIVERY SYSTEM; DRUG DOSE; DRUG EFFICACY; DRUG RELEASE; DRUG SAFETY; EMERGENCY; ENERGY RESOURCE; ENZYME REPLACEMENT; GAUCHER DISEASE; GENETIC SCREENING; GLAUCOMA; GLUCOSE BLOOD LEVEL; IMPLANT; IMPLANTABLE DRUG DELIVERY SYSTEM; INFORMATION PROCESSING; INTRAOCULAR PRESSURE; MEDICAL CARE; MICROELECTROMECHANICAL SYSTEM; NANOELECTROMECHANICAL SYSTEM; PAIN; PRIORITY JOURNAL; PULSATILE DRUG RELEASE; PUMP; REVIEW; WIRELESS COMMUNICATION;

DRUG DELIVERY SYSTEMS; EQUIPMENT DESIGN; HUMANS; INDIVIDUALIZED MEDICINE; INFUSION PUMPS, IMPLANTABLE; MICRO-ELECTRICAL-MECHANICAL SYSTEMS; NANOTECHNOLOGY;

EID: 77955502338     PISSN: 19395116     EISSN: 19390041     Source Type: Journal    
DOI: 10.1002/wnan.93     Document Type: Review

References (134)

1. Jain KK. Future of personalized medicine, Chapter 18. In: Textbook of Personalized Medicine. New York: Springer; 2009, 395-406.
2. Kim K, Lee J-B. MEMS for drug delivery, Chapter 12. In: Wang W, Soper SA, eds. Bio-MEMS: Technologies and Applications. Boca Raton, FL: CRC Press; 2006, 325-348.
3. Colombo P, Sonvico F, Colombo G, Bettini R. Novel platforms for oral drug delivery. Pharm Res 2009, 26:601-611.
4. Santini JT Jr, Richards AC, Scheidt RA, Cima MJ, Langer RS. Microchip technology in drug delivery. Ann Med 2000, 32:377-379.
5. Santini JT Jr, Cima MJ, Langer R. A controlled-release microchip. Nature 1999, 397:335-338.
6. Tao SL, Desai TA. Microfabricated drug delivery systems: from particles to pores. Adv Drug Deliv Rev 2003, 55:315-328. (Pubitemid 36293790)
7. Gardner DP. Microfabricated nanochannel implantable drug delivery devices: trends, limitations and possibilities. Exp Opin Drug Deliv 2006, 3:479-487.
8. Shrivistava S, Dash D. Applying nanotechnology to human health. J Nanotech 2009, 2009:1-14.
9. Shrivastava S. Nanofabrication for drug delivery and tissue engineering. Digest J Nanomat 2008, 3:257-263.
10. Tao SL, Lubeleya MW, Desai TA. Bioadhesive poly(methyl methacrylate)microdevices for controlled drug delivery. J Con Rel 2003, 88:215-228. (Pubitemid 36287339)
11. US Food and Drug Administration. Nanotechnology page. Available at: http://www.fda. gov/nanotechnology/. (Accessed February 1, 2010).
12. Sade RM, American Medical Association. Radio Frequency ID Devices in Humans, CEJA Report 5-A-07, 2007.
13. Staples M, Daniel K, Cima MJ, Langer R. Application of micro- and nano-electromechanical devices to drug delivery. Pharm Res 2006, 23:847-863. (Pubitemid 43781393)
14. Okumu FW, Cleland JL. Implants and injectables. In: Rathbone MJ, Hadgraft J, Roberts MS, eds. Modified Release Drug Delivery Technology. New York: Marcel Dekkar; 2003, 633-638.
15. US Food and Drug Administration. Office of Combination Products page. Available at: http:// www.fda.gov/oc/combination/. (Accessed January 2, 2010).
16. Portnoy S, Koepke S. Obtaining FDA approval of drug/device combination products. Part I: regulatory strategy considerations for preclinical testing. PharmaNet Consulting. Available at: http:// www.pharmanet-cro.com/pdf/ whitepapers/Combo Products.pdf. (Accessed January 2, 2010).
17. The Personalized Medicine Coalition. Home page. Available at: http://www.personalizedmedicinecoaliti on.org/sciencepolicy/personalmed-101 overview.php. (Accessed January 2, 2010).
18. Amgen. Future of biotechnology in healthcare, Chapter 9. In: An Introduction to Biotechnology. 2009, 31-35. Available at: http://www. amgenscholars.eu/web/guest/future-of-biotechnology -in-healthcare. (Accessed January 2, 2010).
19. Heller A. Integrated medical feedback systems for drug delivery. Am Inst Chem Eng J 2005, 51:1054-1066. (Pubitemid 40554068)
20. Brunetti P, Federici MO, Benedetti MM. The artificial pancreas. Artif Cells Blood Substit Immobil Biotechnol 2003, 31:127-138.
21. Elman NM, Ho Duc HL, Cima MJ. An implantable MEMS drug delivery device for rapid delivery in ambulatory emergency care. Biomed Microdevices 2009, 11:625-631.
22. Robertson TL, Hafezi H. Personal paramedic, US20080058772A1.
23. Singer I, Edmonds HL. Head-up tilt testing predicts syncope during ventricular tachycardia in implantable cardioverter defibrillator patients. J Interv Cardiol 1998, 11:205-211. (Pubitemid 28304774)
24. Fonarow GC, Feliciano Z, Boyle NG, Knight L, Woo MA, et al. Improved survival in patients with non-ischemic advanced heart failure and syncope treated with implantable cardioverter - defibrillator. Am J Cardiol 2000, 85:981-985. (Pubitemid 30176138)
25. Cavaco D, Adragao P, Aguiar C, Neves J, Abecasis M, et al. Syncope in implantable cardioverter - defibrillator pacemaker dependent patients. Eur Heart J 2002, 23:665-665.
26. Sanchez JM, Katsiyiannis WT, Gage BF, Chen J, Faddis MN, et al. Implantable cardioverter-defibrillator therapy improves long-term survival in patients with unexplained syncope, cardiomyopathy, and a negative electrophysiologic study. Heart Rhythm 2005, 2:367-373. (Pubitemid 40439281)
27. Moran EG, Mont L. Incidence of syncope after ICD implantation: low or high? Eur Heart J 2006, 27:2481-2482. (Pubitemid 44522157)
28. Hu M, Lindemann T, Göttsche T, Kohnle J, Zengerle R, et al. Discrete chemical release from a microfluidic chip. J Microelectromech Syst 2007, 16:786-794. (Pubitemid 47278821)
29. Genzyme Corporation. Form 10-K. Annual Report for the fiscal year ended December 31, 2009. Available at: http://www.genzyme.com/corp/investors/XBRL/As- Filed 2009 GENZ Form 10-K.pdf. (Accessed May 1, 2010).
30. Genzyme website. The cost of enzyme replacement therapy. Available at: http://www.genzyme.com/ commitment/patients/costof treatment.asp. (Accessed January 2, 2010).
31. IMS Health. Decline in Growth of Prescription Drug Revenue is Forecast, New York: The Associated Press; Aug 9 2009.
32. BCC Research. Advanced Drug Delivery Systems: New Developments, New Technologies. 2009.
33. Madou MJ. Fundamentals of Microfabrication. 2nd ed. Boca Raton, FL: CRC Press; 2002.
34. Ainslie KM, Desai TA. Microfabricated implants for applications in therapeutic delivery, tissue engineering, and biosensing. Lab Chip 2008, 8:1864-1878.
35. Betancourt T, Brannon-Peppas L. Micro- and nanofabrication methods in nanotechnological medical and pharmaceutical devices. Int J Nanomed 2006, 1:483-495.
36. Santini JT Jr, Cima MJ, Langer RS. Method for making microchip reservoir device, US20070047926A1, 2008.
37. Santini JT Jr, Cima MJ, Langer RS. Microchip drug delivery devices, US007070590B1, 2006.
38. Santini JT Jr, Cima MJ, Langer RS. Medical device with array of electrode-containing reservoirs, US007070592B2, 2006.
39. Santini JT Jr, Hutchinson CE, Uhland SA, Cima MJ, Langer RS, et al. Microfabricated devices for the delivery of molecules into a carrier fluid, US006537256B2, 2003.
40. Grayson AR, Johnson A, Flynn N, Li Y, Cima MJ, et al. A bioMEMS review: MEMS technology for physiologically integrated devices. Proc IEEE 2004, 92:6-21. (Pubitemid 40890769)
41. LaVan DA, McGuire T, Langer R. Small-scale systems for in vivo drug delivery. Nat Biotechnol 2003, 21:1184-1191. (Pubitemid 37186175)
42. Tsai H-KA, Ma K-S, Wang C, Xu H, Wang C, et al. Development of integrated protection for a miniaturized drug delivery system. Smart Mater Struct 2007, 16:S295-S299.
43. Tsai H-KA, Madou M. Microfabrication of bilayer polymer actuator valves for controlled drug delivery. JALA 2007, 12:291-295.
44. Gilad P. Electronically-controlled device for release of drugs, proteins, and other organic or inorganic chemicals, US20090216176A1, 2009.
45. Langereis G, Iordanov VP, van Bruggen MPB, Krijnsen HC. Device for the controlled release of a substance and method of releasing substance, US20090099553A1, 2009.
46. Xu H, Wang C, Wang C, Zoval J, Madou M. Polymer actuator valves toward controlled drug delivery application. Biosens Bioelectron 2006, 21:2094-2099.
47. Wood K, Zacharia N, Cunningham PH, Delongchamp D. Electronically- degradable layer-by-layer thin films, US20090088679A1, 2009.
48. Santini JT Jr, Richards AC, Scheidt R, Cima MJ, Langer R. Microchips as implantable drug delivery devices. Angew Chem Int Ed Engl 2000, 39:2396-2407.
49. Razzacki SZ. Integrated microsystems for controlled drug delivery. Adv Drug Deliv Rev 2004, 56:185-198.
50. Grayson ACR, Shawgo RS, Li Y, Cima MJ. Electronic MEMS for triggered delivery. Adv Drug Deliv Rev 2003, 56:173-184.
51. Ge D, Tian X, Qi R, Huang S, Mu J, et al. A polypyrrole-based microchip for controlled drug release. Electrochim Acta 2009, 55:271-275.
52. d'Alarcao M, Calias P. Electrochemically degradable polymers, US20090024074A1, 2009.
53. Gravesen P, Branebjerg J, Jensen OS. Micro Fluidics - a review. J Micromech Microeng 1993, 3:168-182.
54. Shoji S, Esashi M. Microflow devices and systems. J Micromech Microeng 1994, 4:157-171.
55. Sato S, Ebert CD, Kim SW. Prevention of insulin self-association and surface adsorption. J Pharm Sci 1983, 72:228-232.
56. Brennan JR, Gebhart SS, Blackard WG. Pump-induced insulin aggregation. A problem with the Biostator. Diabetes 1985, 34:353-359.
57. der Veen ME, van Iersel DG, van der Goot AJ, Boom RM. Shear-induced inactivation of alphaamylase in a plain shear field. Biotechnol Prog 2004, 20:1140-1145.
58. Amirouche F, Zhou Y, Johnson T. Current micropump technologies and their biomedical applications. Microsys Tech 2009, 15:647-666.
59. White NM. The origins and the future of microfluidics. Nature 2006, 442:368-373.
60. Smits JG. Piezoelectric micropump with three valves working peristaltically. Sens Actuators 1990, A21-A23:203-206.
61. Reynaerts D, Peirs J, Brussel HV. An implantable drug delivery system based on shape memory alloy microactuation. Sens Actuators A Phys 1997, 61:455-462.
62. Benard WL, Kahn HA, Heuer H, Huff MA. Thin film shape memory alloy actuated micropumps. J Microelectromech Syst 1998, 7:245-251.
63. Chen L, Choo J, Yan B. The microfabricated electrokinetic pump: a potential promising drug delivery technique. Exp Opin Drug Deliv 2007, 4:119-129.
64. Debiotech products page. Available at: http://www. debiotech.com/ products/msys/mip.html. (Accessed January 2, 2010).
65. Sangkwon N, Ridgeway S, Cao L. Theoretical and experimental study of fluid behavior of a peristaltic micropump. Proceedings of 15th Biennial University/ Government/Industry Microelectronics Symposium, Boise State University, Boise, Idaho, 2003, 312-316.
66. Cao L, Mantell LS, Polla D. Design and simulation of an implantable medical drug delivery system using microelectromechanical systems technology. Sens Actuators A Phys 2001, 94:117-125.
67. Fiering J, Mescher M. Drug delivery apparatus, US20080009836A1, 2008.
68. Prescott JH, Lipka S, Baldwin S, Sheppard NF Jr, Maloney JM, et al. Chronic, programmed polypeptide delivery from an implanted, multireservoir microchip device. Nat Biotechnol 2006, 24:437-438.
69. Prescott JH, Krieger TJ, Lipka S, Staples MA. Dosage form development, in vitro release kinetics, and in vitro-in vivo correlation for leuprolide released from an implantable multi-reservoir array. Pharm Res 2007, 24:1252-1261.
70. Petersen KE. Silicon as a mechanical material. Proc IEEE 1982, 70:420-457.
71. Bhushan B, Burton Z. Adhesion and friction properties of polymers in microfluidic devices. Nanotechnology 2005, 16:467.478.
72. Guse C, Koennings S, Blunk T, Siepmann J, Goepferich A. Programmable implants-from pulsatile to controlled release. Int J Pharm 2006, 314:161-169.
73. Haykin S. Neural Networks: A Comprehensive Foundation. New York: Prentice Hall; 1998.
74. Ahmed FE. Artificial neural networks for diagnosis and survival prediction in colon cancer. Mol Cancer 2005, 4:29.
75. Achanta AS, Kowalski JG, Rhodes CT. Artificial neural networks: implications for pharmaceutical sciences. Drug Dev Ind Pharm 1995, 21:119-155.
76. Agatonovic-Kustrin S, Beresford R. Basic concepts of artificial neural network (ANN) modeling and its application in pharmaceutical research. J Pharm Biomed 2000, 22:717-727.
77. Zdeblick MJ, Robertson T. Medical diagnostic and treatment platform using near-field wireless communication of information within a patient's body, US20080306359A1, 2008.
78. Zdeblick MJ, Thompson A, Pikelny A, Robertson T. Pharma-informatics system, US20080284599A1, 2008.
79. Smith S, Tang TB, Stevenson JTM, Flynn BW, Reekie HM, et al. Miniaturized drug delivery system with wireless power transfer and communication. IET Nanobiotechnol 2007, 1:80-86.
80. U.S. Food and Drug Administration. Draft Guidance for Industry and FDA Staff Radio-Frequency Wireless Technology in Medical Devices. Draft released for comment on January 3, 2007. Available at: http://www.fda.gov/downloads/ MedicalDevices/ DeviceRegulationandGuidance/GuidanceDocuments/ ucm077272.pdf. (Accessed May 1, 2010).
81. Sheppard N, Santini JT Jr, Cima MJ, Langer RS, Ausiello D. Method for wirelessly monitoring implanted medical device, US20080221555A1, 2008.
82. de Avila J. Your iPhone just called: your blood-sugar is high. Wall St J (East Ed) December 21, 2009, D1-D2.
83. Bequette BW. A critical assessment of algorithms and challenges in the development of a closed-loop artificial pancreas. Diabetes Technol Ther 2005, 7:28-47.
84. Tang TB, Smith S, Flynn BW, Stevenson JTM, Gundlach AM, et al. Implementation of wireless power transfer and communications for an implantable ocular drug delivery system. IET Nanobiotechnol 2008, 2:72-79.
85. Santini JT Jr, Ausiello D. Pre-clinical animal testing method, US20080083041A1, 2008.
86. Smith S, Tang TB, Terry JG, Stevenson JTM, Flynn BW, et al. Development of a miniaturised drug delivery system with wireless power transfer and communication. IET Nanobiotechnol 2007, 1:80-86.
87. Coppeta JR, Uhland SA, Polito BF, Sheppard NF Jr, Feakes CM, et al. Hermetically sealed devices for controlled release or exposure of reservoir contents, US20070036835A1, 2007.
88. Daniel K, Duc HLH, Cima MJ, Langer RS. Controlled release microchips, Chapter 9. In: Youan B-BC, ed. Chronopharmaceutics. New York: John Wiley & Sons; 2009, 187-215.
89. Sharma S, Nijdam AJ, Sinha PM, Walczak RJ, Liu X, et al. Controlled-release microchips. Exp Opin Drug Deliv 2006, 3:379-394.
90. Huang W-C, Hu S-H, Liu K-H, Chen S-Y, Liu D-M. A flexible drug delivery chip for the magnetically-controlled release of anti-epileptic drugs. J Controlled Release 2009, 139:221-228.
91. Intra J, Glasgow JM, Mai HQ, Salem AK. Pulsatile release of biomolecules from polydimethylsiloxane (PDMS) chips with hydrolytically degradable seals. J Controlled Release 2008, 127:280-287.
92. Kim GY, Tyler BM, Tupper MM, Karp JM, Langer RS, et al. Resorbable polymer microchips releasing BCNU inhibit tumor growth in the rat 9L flank model. J Controlled Release 2007, 123:172-178.
93. Richards AC, Santini JT Jr, Cima MJ, Langer RS. Multi-reservoir device for controlled drug delivery, US20060189963A1, 2006.
94. Shawgo RS, Grayson ACR, Li Y, Cima MJ. BioMEMS for drug delivery. Curr Opin Solid State 2002, 6:329-334.
95. Li Y, Shawgo RS, Tyler BM, Henderson PT, Vogel JS, et al. In vivo release from a drug delivery MEMS device. J Controlled Release 2004, 100:211-219.
96. Li Y, Duc HLH, Tyler BM, Williams T, Tupper M, et al. In vivo delivery of BCNU from a MEMS device to a tumor model. J Controlled Release 2005, 106:138-145.
97. Chung A, Kim D, Erickson D. Electrokinetic microfluidic devices for rapid, low power drug delivery in autonomous microsystems. Lab Chip 2008, 8:330-338.
98. Maloney JM, Uhland SA, Polito BF, Sheppard NF Jr, Pelta CM, et al. Electrothermally activated microchips for implantable drug delivery and biosensing. J Controlled Release 2005, 109:244-255.
99. Uhland SA, Polito B, Maloney JM, Sheppard NF, Herman SJ, et al. Method for making device for controlled reservoir opening by electrothermal ablation, US20080168921A1, 2008.
100. Santini JT Jr, Cima MJ, Langer RS. Method for operating microchip reservoir device. US20080051766A1, 2008.
101. Johnson AM, Cima MJ, Langer RS. Microscale lyophilization and drying methods for the stabilization of molecules, US007354597B2, 2008.
102. Proos ER, Prescott JH, Staples MA. Long-term stability and in vitro release of hPTH(1-34) from a multireservoir array. Pharm Res 2008, 25:1387-1395.
103. Prescott JH, Krieger T, Proos ER. Control of drug release by transient modification of local microenvironments, US007488316B2, 2009.
104. Ausiello D, Santini JT Jr, Herman SJ, Prescott JH, Uhland SA, et al. Implantable device for controlled, extended delivery of parathyroid hormone, US20090163895A1, 2009.
105. Ausiello D, Santini JT Jr, Herman SJ, Prescott JH. Method and device for the controlled delivery of parathyroid hormone, US20040082937A1, 2004.
106. Liu X, Pettway GJ, McCauley LK, Ma PX. Pulsatile release of parathyroid hormone from an implantable delivery system. Biomaterials 2007, 28:4124-4131.
107. Santini JT Jr, Hutchinson CE, Proos ER. Medical and dental implant devices for controlled drug delivery, US20070016163A1, 2007.
108. Martinson JB, Stark JG, Hanson TJB, Backes SJ. Instrumented orthopedic and other medical implants, US20060271112A1, 2006.
109. Santini JT Jr, Cima MJ, Langer RS, Ausiello D, Sheppard NF. Method of opening reservoir of containment device, US20080221557A1, 2008.
110. Santini JT Jr, Cima MJ, Langer RS, Ausiello D, Sheppard NF. Method of actuating implanted medical device. US20080071252A1, 2008.
111. Sugiura S, Sumaru K, Ohi K, Hiroki K, Takagi T, et al. Photoresponsive polymer gel microvalves controlled by local light irradiation. Sens Actuators, A 2007, 140:176-184.
112. Johnson MT, Kurt R. Device for the controlled release of a predefined quantity of a substance, US20080208174A1, 2008.
113. Langer R. Drugs on target. Science 2001, 293:58-59.
114. Traitel T, Goldbart R, Kost J. Smart polymers for responsive drug-delivery systems. J Biomater Sci Polym Ed 2008, 19:755-767.
115. Satarkar NS, Hilt JZ. Magnetic hydrogel nanocomposites for remote controlled pulsatile drug release. J Controlled Release 2008, 130:246-251.
116. Yoshida R, Sakai T, Hara Y, Maeda S, Hashimoto S, et al. Self oscillating gel as novel biomimeticmaterials. J Controlled Release 2009, 140:186-193.
117. Yoshida R. Design of functional polymer gels and their application to biomimetic materials. Curr Org Chem 2005, 9:1617-1641.
118. Okano T, ed. Biorelated Polymers and Gels: Controlled Release and Applications in Biomedical Engineering. London: Academic Press; 1998.
119. Peppas NA, Hilt JZ, Khademhosseini A, Langer R. Hydrogels in biology and medicine: from molecular principles to bionanotechnology. Adv Mater (Weinheim, Ger) 2006, 18:1345-1360.
120. Jun SB, Hynd MR, Dowell-Mesfin NM, Al-Kofahi Y, Roysam B, et al. Modulation of cultured neural networks using neurotrophin release from hydrogel-coated microelectrode arrays. J Neural Eng 2008, 5:203-213.
121. Kikuchi A, Okano T. Pulsatile drug release control using hydrogels. Adv Drug Deliv Rev 2002, 54:53-77.
122. Kataoka K, Miyazaki H, Bunya M, Okano T, Sakurai Y. Totally synthetic polymer gels responding to external glucose concentration: their preparation and application to on-off regulation of insulin release. J Am Chem Soc 1998, 120:12694-12695.
123. Matsumoto A, Yoshida R, Kataoka K. Glucose-responsive polymer gel bearing phenylborate derivative as a glucose-sensing moiety operating at the physiological pH. Biomacromolecules 2004, 5:1038-1045.
124. Hoffman AS. Hydrogels for biomedical applications. Adv Drug Deliv Rev 2002, 43:3-12.
125. Miyata T, Uragami T, Nakamae K. Biomolecule-sensitive hydrogels. Adv Drug Deliv Rev 2002, 54:79-98.
126. Kiser PF, Wilson G, Needham D. A synthetic mimic of the secretory granule for drug delivery. Nature 1998, 394:459-462.
127. Yeghiazarian LL, Wiesner U, Montemagno CD. Volume phase transition to induce gel movement, US007313917B2, 2008.
128. Phyllis Gardner P. Microfabricated nanochannel implantable drug delivery devices: trends, limitations and possibilities. Adv Drug Deliv Rev 2006, 3:479-487.
129. Randall CL, Leong TG, Bassik N, Gracias DH. 3D lithographically fabricated nanoliter containers for drug delivery. Adv Drug Deliv Rev 2007, 59:1547-1561.
130. Boston Scientific Corporation. Form 10-K. Annual Report for the fiscal year ended December 31, 2004. Available at: http://phx.corporate-ir.net/phoenix. zhtml?c=62272&p=irol-sec&secCat01Enhanced.1-rs = 11&secCat01Enhanced.1 rc=10&control-select group=Annual%20Filings. (Accessed May 1, 2010).
131. Pfizer Inc. 2007 Financial Report. Available at: http://media.pfizer.com/ files/annualreport/2007/ financial/financial2007.pdf. (Accessed May 1, 2010).
132. Bayer AG. Bayer Annual Report 2006. Available at: http://www.bayer.com/ en/GB-2006-en.pdfx. (Accessed May 1, 2010).
133. Vyteris, Inc. Form 10-Q Quarterly Report. Filed November 13, 2009. Available at: http://investor.vyteris.com/. (Accessed May 1, 2010).
134. Alaeea M, Moghadama SH, Sayyara P, Atyabia F, Dinarvanda R. Preparation of a reservoir type levonorgestrel delivery system using high molecular weight poly L-lactide. Iran J Pharm Res 2009, 8:87-93.